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Aim of Study: In-vitro studies investigating the mechanism of 
action of glucosamine sulfate in osteoarthritis have been mostly 
performed at high glucosamine concentrations. Recent studies in 
man have shown that after administration of the standard 1500 
mg once-a-day oral therapeutic dose of glucosamine sulfate for 
osteoarthritis, average maximum plasma concentrations of glu- 
cosamine are in the 10 I~M range. The aim of the present study 
was to investigate in a human chondrocyte-like cell model, the 
effects of glucosamine sulfate at these concentrations on IL- 
l-induced gene expression of different inflammation or matrix 
degradation markers. In addition, the effect of 10 I~M glucosamine 
sulfate was studied on P-IkB levels in the cytoplasm. IkB is the in- 
hibitory protein that maintains the transcription factor NFkB in an 
inactivated state: when phosphorilated, it is released from NF-kB 
that can thus enter the nucleus. 
Methods: Human chondrosarcoma cells SW 1353 were grown 
to confluence and stimulated with 2 ng/ml IL-11~, i.e. the optimal 
stimulatory concentration in pilot experiments. Cells were incu- 
bated in drug-free medium or containing glucosamine sulfate be- 
tween 0.001 and 100 I~M. RealTime PCR was used to quantify 
gene expression levels after optimal exposure, that was 6 hours 
for Cox-2, iNOS, IL-11~, IL-6 and MMP-3, 1 hour for TNF~ and 24 
hours for ADAMTS5 (aggrecanase-2). All experiments were run 
in triplicate. Results were expressed as glucosamine concentra- 
tions able to decrease by 50% (IC50) the stimulation by IL-11~. 
P-IkB levels were determined by Western Blot: cell lysates of SW 
1353 stimulated for 45 min with 2 ng/ml IL-11~ were analysed by 
SDS-PAGE, detection being performed using ECL (Amersham) 
and quantitation by densitometry analysis using NIH Image soft- 
wa re. 
Results: Glucosamine sulfate decreased the strongly IL-11~- 
stimulated gene expression of all transcripts considered, with glu- 
cosamine IC50 close to 10 I~M or lower (Table 1). 
Table 1. Glucosamine IC 50 (/zM ± SE) on IL- 1b-stimulated gene 
expression of different markers 
cox-2 iNOS IL-1 b IL-6 MMP-3 TNF-a ADAMTS5 
11.2±1.2 13.8±5.6 6.2±3.0 4.4±1.1 10.2±2.3 12.8±2.0 2.8±0.7 
IL-11~ stimulation induced a strong activation of NFkB and there- 
fore a parallel 4-fold increase in P-IkB cytoplasmic levels. Glu- 
cosamine sulfate inhibited this increase by 93% at the concentra- 
tion used. 
Conclusions: Glucosamine sulfate inhibits IL-1-stimulated gene 
expression of different inflammation or matrix degradation mark- 
ers in a human chondrocyte-like cell model, at glucosamine con- 
centrations found in human plasma after oral therapeutic doses. 
These results confirm previous observations obtained with higher 
glucosamine concentrations and that these events are probably 
initiated by a decrease in NFkB activation and nuclear transloca- 
tion. 
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OA JOINT FLUID IS DEFICIENT IN CRITICAL 
ANTIOXIDANTS 
EA Regan, RP Bowler, JD Crapo 
Department of Medicine, National Jewish Medical and Research 
Center, Denver, CO 
Aim of Study: To determine if extracellular superoxide dismu- 
tase (EC-SOD) in human joint fluid reflects the deficiency in this 
enzyme found in OA cartilage. 
Methods: Human joint fluid was collected from patients under- 
going arthrocentesis for diagnosis or joint injection (OA patients, 
n=40) or from patients undergoing arthroscopy for meniscal tears 
or ACL reconstruction (Controls, n=12). Superoxide dismutase 
(SOD) activity was measured by cytochrome C assay. The extra- 
cellular SOD isoenzyme protein was determined with an ELISA. 
Urate and ascorbate were measured using HPLC. Reduced and 
oxidized glutathione (GSH/GSSG) were measured with a col- 
orimetic technique (OxisResearch) and TGF beta and IL-6 were 
measured with ELISA. Total antioxidant power was also mea- 
sured with a colorimetic reduction of copper (Oxford) and ni- 
trates/nitrites were measured with the Griess reaction. Western 
blots were done for EC-SOD to assess the percentage of the pro- 
tein with and without it's heparin binding site and compared to 
cartilage tissue extracts. 
Results: The major catalytic antioxidant found in human joint 
fluid is extracellular superoxide dismutase (EC-SOD) and it was 
decreased fifty percent in the OA joint fluid samples (p=O.O03). 
Western blots showed that in joint fluid the extracellular ma- 
trix (ECM)-binding site of EC-SOD is cleaved in 70% of the 
molecules. In cartilage tissue from controls only about 25% of 
EC-SOD molecules have the binding site cleaved. The relative 
percent of cleaved enzyme in OA joint fluid is greater than in 
control joint fluid. The low molecular weight antioxidants: ascor- 
bate (p=0.02), oxidized glutathione (p=0.002), and reduced glu- 
tathione (0.001) were significantly decreased in the OA samples. 
Conclusions: We find that there are marked decreases in both 
enzymatic (EC-SOD) and low molecular weight antioxidants in 
OA joint fluid. We have previously shown that EC-SOD is pro- 
foundly decreased in both human OA cartilage and in a mouse 
model of OA (STR/ort mouse). In this model there is an in- 
adequate EC-SOD response to high oxidant stress levels. Os- 
teoarthritis is associated with increased production of inflamma- 
tory cytokines and ultimate mechanical failure of the articular car- 
tilage ECM. Excess oxidants lead to activation of MMP's and 
damage to the structural molecules of the ECM, that exacerbates 
the vulnerability of the tissue to mechanical damage. The finding 
of decreases in critical joint fluid extracellular antioxidants further 
supports the observation that oxidant damage plays an important 
role in the pathogenesis of OA. These results in joint fluid suggest 
that there is an inadequate response to oxidant stress in patients 
with symptomatic disease. Loss of adequate oxidant scavenging 
from the joint fluid may intensify or initiate the oxidant stress found 
in OA cartilage. Measuring joint fluid antioxidants may be a sen- 
sitive test for identifying early arthritis. 
